DocGo (DCGO) Stock Price, News & Analysis

Company Overview

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Key Stats

• Today's Range: $4.77 to $5.12
• 50-Day Range: $4.02 to $5.60
• 52-Week Range: $2.75 to $5.68
• Volume: 693,753 shs
• Average Volume: 560,325 shs
• Market Capitalization: $488.82 million
• P/E Ratio: 17.11
• Dividend Yield: N/A
• Price Target: $6.10
• Consensus Rating: Buy

DocGo Stock Analysis - MarketRank™

DocGo scored higher than 47% of companies evaluated by MarketBeat, and ranked 845th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

DocGo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

DocGo has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: -68.00%

Earnings Growth

Earnings for DocGo are expected to decrease by -68.00% in the coming year, from $0.25 to $0.08 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of DocGo is 17.11, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.57.

Price to Earnings Ratio vs. Sector

The P/E ratio of DocGo is 17.11, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.46.

Price to Earnings Growth Ratio

DocGo has a PEG Ratio of 15.51. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

DocGo has a P/B Ratio of 1.63. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.22% of the float of DocGo has been sold short.

Short Interest Ratio / Days to Cover

DocGo has a short interest ratio ("days to cover") of 10.4, which indicates bearish sentiment.

Change versus previous month

Short interest in DocGo has recently increased by 2.86%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

DocGo does not currently pay a dividend.

Dividend Growth

DocGo does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

8.22% of the float of DocGo has been sold short.

Short Interest Ratio / Days to Cover

DocGo has a short interest ratio ("days to cover") of 10.4, which indicates bearish sentiment.

Change versus previous month

Short interest in DocGo has recently increased by 2.86%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.32

News Sentiment

DocGo has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for DocGo this week, compared to 3 articles on an average week.

Search Interest

7 people have searched for DCGO on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.

MarketBeat Follows

1 people have added DocGo to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, DocGo insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $102,511.00 in company stock.

Percentage Held by Insiders

Only 2.70% of the stock of DocGo is held by insiders.

Percentage Held by Institutions

56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DCGO Stock Analysis - Frequently Asked Questions

How have DCGO shares performed this year?

DocGo's stock was trading at $4.24 at the beginning of the year. Since then, DCGO shares have increased by 13.0% and is now trading at $4.79.
View the best growth stocks for 2025 here.

How were DocGo's earnings last quarter?

DocGo Inc. (NASDAQ:DCGO) issued its quarterly earnings results on Thursday, November, 7th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.01. The business had revenue of $138.68 million for the quarter, compared to the consensus estimate of $139.59 million. DocGo had a net margin of 4.35% and a trailing twelve-month return on equity of 8.90%.

Who are DocGo's major shareholders?

DocGo's top institutional investors include Deerfield Management Company L.P. Series C (7.05%), Vanguard Group Inc. (4.91%), WCM Investment Management LLC (4.23%) and Northern Trust Corp (1.57%). Insiders that own company stock include Lee Bienstock, Adriaan Stephanus Oberholzer, James M Travers, Anthony Capone, Ely D Tendler and Stephen Sugrue.
View institutional ownership trends.

How do I buy shares of DocGo?

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of DocGo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), Adobe (ADBE), Broadcom (AVGO), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

• Last Earnings: 11/07/2024
• Today: 2/21/2025
• Next Earnings (Confirmed): 2/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Health services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:DCGO
• CUSIP: N/A
• CIK: 1822359
• Web: www.docgo.com
• Phone: 844-443-6246
• Fax: N/A
• Employees: 4,164
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $6.10
• High Stock Price Target: $7.00
• Low Stock Price Target: $5.00
• Potential Upside/Downside: +27.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 5 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.28
• Trailing P/E Ratio: 17.11
• Forward P/E Ratio: 19.16
• P/E Growth: 15.51
• Net Income: $6.86 million
• Net Margins: 4.35%
• Pretax Margin: 6.69%
• Return on Equity: 8.90%
• Return on Assets: 5.72%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.19
• Quick Ratio: 2.19

Sales & Book Value

• Annual Sales: $624.29 million
• Price / Sales: 0.78
• Cash Flow: $0.19 per share
• Price / Cash Flow: 25.88
• Book Value: $2.93 per share
• Price / Book: 1.63

Miscellaneous

• Outstanding Shares: 102,050,000
• Free Float: 99,296,000
• Market Cap: $488.82 million
• Optionable: Optionable
• Beta: 1.00